Answer:
The financial scorecard perspective is the most appropriate. With it, the pharmaceutical company will be able to look at how its financial decisions related to the development of the new drug affect the stakeholders (stockholders, unions, and consumers).
After completing the scorecard, the pharmaceutical company will be able to balance its financial decisions in order to cause the least problems to all stakeholders (some stakeholders will be more affected than others by any decision).